fda glp-1 warning letters october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading Drug ad enforcement ramps up–again

Rowland on the Eastern Division is presiding over these cases, where discovery is currently ongoing

Other non-entero-pancreatic hormone-based pharmacotherapies such as bimagrumab and growth differentiation factor 15 (GDF-15) are also under investigation

Item 2 of 20 Create flawless lipstick looks with these expertly colour-matched lip liner and lipstick combinations

Medicamentos GLP-1 impactam gastos alimentares nos EUA Um estudo da Universidade Cornell e do grupo de insights Numerator revelou que famlias nos Estados Unidos com usurios de medicamentos GLP-1, como Wegovy e Ozempic, reduziram seus gastos com alimentos em uma mdia de 5,5% nos seis meses aps o incio do tratamento